"procedural data" is a correct and usable phrase in written English.
It is typically used to refer to data collected during or resulting from a process, such as an experiment or other systematic procedure. For example: "The procedural data gathered during the experiment indicated the hypothesis was correct."
LOS and procedural data (procedure time, number of lesions treated, stents utilized, and balloons utilized) were collected from the participating COMPLIANCE 360° study sites.
The data to be collected includes patient demographics, procedural data (surgical procedure, length of stay in PACU), and nursing assessment of patient readiness for discharge from PACU, nursing handover from PACU to ward nurse, patient outcomes (PACU discharge destination, any complications and adverse events in PACU).
Among the procedural data, only duration of the procedure (shorter in the direct stenting group), the number of balloons used, and the quantity of contrast agent (lower in the direct stenting group) were significantly different between the 2 groups (P <.05).
Where the procedure was performed at another institution, procedural data was extracted from urologists' medical records.
Secondary end points included procedural data, total radiation exposure, total procedure duration, and occurrence of adverse events, including PNP (assessed with breathing or pacing maneuvers at the discretion of the physician), pericardial effusion, and vascular complications.
Integrated within the VA electronic health record, the CART program uses a specialized software platform to collect real-time patient and procedural data for all VA patients undergoing coronary procedures in VA catheterization laboratories.
The per-protocol dataset is a subset of the intention-to-treat dataset excluding patients randomized but not complying with all inclusion and exclusion criteria, patients deviating from the study protocol to such extent that they might introduce bias in the intention-to-treat analysis, and the post-procedural data from patients randomized to the control group, but crossing over to RDN.
For empiric validation, we use procedural patent data from the European patent application process.
This review will discuss and compare the technology and procedural outcomes data of the current FDA-approved EVAR devices.
For other, mainly procedural factors, data appear relatively scarce.
The methods we have used to analyse the procedural specification data also allow updating of the results by further iteration.
